The Growing Problem of Polypharmacy in Pakistan: An Urgent Need for Intervention

Polypharmacy, defined as the concurrent use of five or more medications, is a growing public health concern in Pakistan, particularly among the elderly and those with multiple chronic conditions. The prevalence of polypharmacy is alarmingly high, with studies indicating rates between 20% to 50% in various healthcare settings. Contributing factors include the rising burden of non-communicable diseases, a lack of standardized prescribing practices, and inadequate regulation of the pharmaceutical industry. The consequences of polypharmacy are severe, leading to increased adverse drug reactions, drug-drug interactions, non-adherence, and higher healthcare costs. Addressing this issue requires a multi-faceted approach: promoting rational prescribing practices, improving care coordination, educating patients and caregivers, and strengthening pharmaceutical regulations. A comprehensive strategy is essential to enhance health outcomes and quality of life for patients in Pakistan.